Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

InVite® Health Introduces New Antioxidant Dietary Supplement – GliSODin® with Catalase
  • USA - English


News provided by

InVite Health

Aug 05, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

GliSODin with Catalase
GliSODin with Catalase

The powerful and sustained antioxidant protection that GliSODin® with Catalase supplies may help protect the quality of its users’ lifespan and healthspan

Post this

New York, NY (PRWEB) August 05, 2013 -- InVite® Health, a leading nutraceutical firm headquartered in New York City, today announced the introduction of its new GliSODin® with Catalase a clinically-studied patent form of Super Oxide Dismutase (SOD), an antioxidant present in cells exposed to oxygen. SOD is the primary antioxidant released by the body to defend itself. Catalase, a second antioxidant enzyme, helps to protect our cells during energy production. It is also believed to support the skin’s natural defenses. As we age our SOD and catalase levels diminish. This also occurs when free radical production is high. When combined, these antioxidants offer cellular protection from the most potent free radical, known to damage cells - hydrogen peroxide, superoxide and peroxynitrate. Invite Health’s GliSODin® with Catalase dietary supplement provides 150 mg of SOD sourced from cantaloupe and wheat protein, supported by 25mg of Catalase.

GliSODin® with Catalase supplies the body's two most important and protective antioxidant- enzymes Superoxide Dismutase (also known as SOD) plus Catalase. Singlet oxygen is a remarkably unstable form of oxygen that is persistent and damages tissues in major organs such as the heart and brain. SOD reduces singlet oxygen to peroxide which is far less damaging. Catalase then reduces the body’s peroxide levels to the safe metabolites Oxygen (the stable, normal kind you breathe in) and water. Users can be assured that the product offers additional processing and delivery system features that Invite Health is known for including:

• Vegetarian Vcaps® capsule
• Convenient once or twice a day dosing
• Uses GliSODin, an ingredient successfully used in many published clinical trials
• Made using GMP (Good Manufacturing Practices)

“The powerful and sustained antioxidant protection that GliSODin® with Catalase supplies may help protect the quality of its users’ lifespan and healthspan,” comments Dr. Millie Lytle, a Nutritional Director at InVite® Health, Inc. She notes: “The product may help shield the brain, heart, lungs, eyes, kidneys, liver and other organs and tissues from being ravaged by free radicals and other damage caused by inflammation at the cellular level. “

Additionally, Jerry Hickey, R.Ph., who oversees InVite® Health’s Product Development Department and is its Scientific Director, has noted the product has properties beneficial to athletes and fitness-oriented persons. “Buffering muscles during exercise by decreasing the production of lactic acid improves the workout and also speeds the muscles’ post-workout rate of recovery,” Hickey notes. “This action decreases the risk of muscle aches, cramps and injury and may also improve athletic endurance and physical performance,” Hickey concludes.

The combination of antioxidant and anti-inflammatory ingredients are widespread and may also protect the body’s organs from drug toxicity and arthritic joints as well thereby enabling greater comfort and ease when walking. GliSODin® with Catalase supplements are also said to shield the skin from the sun’s aging radiation effects and protect the hair follicle from damage.

About InVite® Health

For more than a decade, InVite® Health has been recognized as an innovator and leader in the nutritional supplement industry. Offering a comprehensive line of the finest quality dietary ingredients from vitamins, herbs, minerals, specialized formulas and personal care products, InVite has built a loyal and growing consumer base. Their solid reputation has been founded on ensuring the highest standards in nutraceutical research and product development, committing to service excellence and assisting with charting and maintaining their clients’ paths to wellbeing.

InVite™ Health is proud to follow Good Manufacturing Practices (GMP) guaranteeing that is stated on the product label, is indeed the good ingredients and serving sizes in the bottle. The firm continues follow through on these guidelines as the FDA updates its new classification current Good Manufacturing Practices (cGMP). Invite Health’s key staff members are trained in cGMP to best understand and continue to update Invite’s products to the highest standard possible, while providing the best product and product knowledge to customers.

Jerry Ruiz, InVite Health, http://www.InViteHealth.com, (800) 349-0929, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.